This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
13 Dec 2019
12:00:00 - 17:00:00
UMRI Multimorbidity research network launch
Dalton Room, Core Technology Facility, Grafton St, Manchester, M13 9WU
The University of Manchester Research Institute (UMRI) Multimorbidity Research Network is organising a network launch event on Friday 13th Dec 2019 at 12noon – 5pm in Dalton Room, Core Technology Facility, Manchester M13 9WU.
The event will be co-hosted by Prof Niels Peek (UMRI network lead; Digital Health), Dr Jenny Humphreys (Rheumatic and Musculoskeletal Diseases (RMD), Prof Evan Kontopantelis (Data Sciences and Health Services Research) and Dr Suzanne Verstappen (RMD Epidemiology, Work).
FBMH Vice Dean for Research & Innovation Prof Nigel Hooper will open the event, and an introduction to the UMRI multimorbidity research network will be provided by Prof Niels Peek, Health eResearch Centre for North England, University of Manchester. The speakers include:
- Prof Stewart Mercer, Professor of Primary Care and Multimorbidity, University of Edinburgh
Multimorbidity, deprivation and the inverse care law - Prof Jose Valderas, Professor of Health Services and Policy Research, University of Exeter
Title TBC – multimorbidity, primary care, and quality of care - Prof Tracy Hussell, Professor of Immunology and the Director of the Lydia Becker Institute of Immunology and Inflammation, University of Manchester
Title TBC – new approaches to multimorbidity research at Lydia Becker Institute of Immunology and inflammation - Dr Ivan Pavlov, UKRI/MRC PSMB Programme Manager (incl. multimorbidities)
UKRI priorities and recent calls including Strategic Priority Fund UKRI-NIHR call on multimorbidity
The programme will include breakout sessions to discuss methodology and clinical challenges, and presentations from recently funded pump-priming studies.